Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia

[1]  B. Mittal,et al.  Association of Functionally Important Polymorphism of Microsomal Epoxide Hydrolase Gene (EPHX1) With Lung Cancer Susceptibility , 2011, Cancer investigation.

[2]  R. Vierkant,et al.  Xenobiotic‐Metabolizing gene polymorphisms and ovarian cancer risk , 2011, Molecular carcinogenesis.

[3]  M. Ingelman-Sundberg,et al.  Genetic polymorphism and toxicology--with emphasis on cytochrome p450. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  C. Tanrikut,et al.  DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. , 2010, Leukemia research.

[5]  T. Isbir,et al.  Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. , 2010, Tumori.

[6]  E. Arinç,et al.  The role of polymorphic cytochrome P450 enzymes in drug design, development and drug interactions with a special emphasis on phenotyping , 2010 .

[7]  C. Scrideli,et al.  Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children , 2009, Environmental and molecular mutagenesis.

[8]  M. Arand,et al.  Mammalian epoxide hydrolases in xenobiotic metabolism and signalling , 2009, Archives of Toxicology.

[9]  B. Mittal,et al.  Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. , 2008, Toxicology and applied pharmacology.

[10]  S. Ahmed,et al.  Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) Polymorphisms in Breast Carcinoma , 2008, BMC Cancer.

[11]  D. Srivastava,et al.  Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India , 2008, Archives of Toxicology.

[12]  R. D. Mittal,et al.  Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. , 2007, DNA and cell biology.

[13]  C. V. van Duijn,et al.  Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population , 2007, BMC Cancer.

[14]  O. Adalı,et al.  Significance of Genetic Polymorphisms at Multiple Loci of CYP2E1 in the Risk of Development of Childhood Acute Lymphoblastic Leukemia , 2007, Oncology.

[15]  O. Adalı,et al.  The low frequency of defective TPMT alleles in Turkish population: A study on pediatric patients with acute lymphoblastic leukemia , 2007, American journal of hematology.

[16]  I. Ember,et al.  Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. , 2007, Anticancer research.

[17]  O. Adalı,et al.  Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population , 2007, Archives of Toxicology.

[18]  S. Z. Abdel‐Rahman,et al.  Detoxification of olefinic epoxides and nucleotide excision repair of epoxide-mediated DNA damage: Insights from animal models examining human sensitivity to 1,3-butadiene. , 2007, Chemico-biological interactions.

[19]  D. Colomer,et al.  The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. , 2007, Haematologica.

[20]  Ş. Arslan,et al.  Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  M. Işcan,et al.  Stimulatory effects of benzene on rabbit liver and kidney microsomal cytochrome P-450 dependent drug metabolizing enzymes , 2006, Archives of Toxicology.

[22]  M. Loriot,et al.  Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[23]  A. Bauer,et al.  Use of genetically modified mouse models to assess pathways of benzene-induced bone marrow cytotoxicity and genotoxicity. , 2005, Chemico-biological interactions.

[24]  Ş. Arslan,et al.  Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver , 2005, Archives of Toxicology.

[25]  N. Özbek.  Çocukluk Çağı Akut Lenfoblastik Lösemisi , 2005 .

[26]  T. Celkan,et al.  NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia , 2004, Pediatric blood & cancer.

[27]  D. Lahiri,et al.  DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality , 1993, Biochemical Genetics.

[28]  M. Hiltunen,et al.  Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome. , 2003, Fertility and sterility.

[29]  F. Oesch,et al.  Detoxification Strategy of Epoxide Hydrolase , 2003 .

[30]  F. Oesch,et al.  Detoxification Strategy of Epoxide Hydrolase The Basis for a Threshold in Chemical Carcinogenesis , 2003 .

[31]  S. Z. Abdel‐Rahman,et al.  A model of sensitivity: 1,3‐butadiene increases mutant frequencies and genomic damage in mice lacking a functional microsomal epoxide hydrolase gene , 2003, Environmental and molecular mutagenesis.

[32]  A. Amorim,et al.  The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal , 2002, Leukemia.

[33]  I. Hickson,et al.  XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein–protein interactions , 2001, The EMBO journal.

[34]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[35]  M. Weinfeld,et al.  XRCC1 Stimulates Human Polynucleotide Kinase Activity at Damaged DNA Termini and Accelerates DNA Single-Strand Break Repair , 2001, Cell.

[36]  O. Adalı,et al.  Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine pretreatment of rabbits , 2000, Archives of Toxicology.

[37]  M. Waters,et al.  A review of the genetic and related effects of 1,3-butadiene in rodents and humans. , 2000, Mutation research.

[38]  O. Adalı,et al.  Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits , 2000, Archives of Toxicology.

[39]  M. Ingelman-Sundberg,et al.  Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. , 1999, Drug metabolism reviews.

[40]  D. Bell,et al.  XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. , 1999, Cancer research.

[41]  D. Labuda,et al.  Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. , 1999, Blood.

[42]  F. Oesch,et al.  Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[43]  D. Harrison,et al.  Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.

[44]  H. Kroemer,et al.  Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approach. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[45]  F. Oesch,et al.  The microsomal epoxide hydrolase has a single membrane signal anchor sequence which is dispensable for the catalytic activity of this protein. , 1994, The Biochemical journal.

[46]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[47]  A. Sen,et al.  Effects of in vivo benzo(a)pyrene treatment on liver microsomal mixed-function oxidase activities of gilthead seabream (Sparus aurata). , 1994, Comparative biochemistry and physiology. Pharmacology, toxicology and endocrinology.

[48]  J. Potter,et al.  Epidemiology of childhood leukemia, with a focus on infants. , 1994, Epidemiologic reviews.

[49]  F E Alexander,et al.  Parental occupations of children with leukaemia in west Cumbria, north Humberside, and Gateshead. , 1991, BMJ.

[50]  M. Ingelman-Sundberg,et al.  Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. , 1988, Cancer research.

[51]  G. Bellucci,et al.  The metabolism of carbamazepine in humans: steric course of the enzymatic hydrolysis of the 10,11-epoxide. , 1987, Journal of medicinal chemistry.

[52]  C. Falany,et al.  Structure and organization of the microsomal xenobiotic epoxide hydrolase gene. , 1987, The Journal of biological chemistry.

[53]  E. Arinç,et al.  Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. , 1976, The Journal of biological chemistry.

[54]  F. Oesch,et al.  Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.